Trading in Collagen Solutions has commenced on Aim.
The renamed Healthcare Investment Opportunities was formed when Collbio, which acquired Collagen Solutions, reversed into it. The Collagen Solutions business “provides medical grade bovine collagen, corium and tendon from closed herd and GBR1 countries and customised collagen based on customer requirements“. There is also a Glasgow-based contract manufacturing operation which used to be owned by Angel Biotechnology.
Dr Stewart White, who previously ran Angel, has been appointed chief executive.
At 14.75p a share, Collagen Solutions is valued at £9.41m. The original shell floated at 10p a share and the consideration shares for Collbio were issued at 12.5p each. Up to £2.76m more could be payable for Collbio depending on performance.
Download the latest AIM Journal from http://wwww.hubinvest.com/AIMPDFDecember2013_51.pdf
© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.